Aspen Aerogels, Inc. (NYSE:ASPN) Holdings Lifted by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. raised its position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 167.2% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 102,535 shares of the construction company's stock after acquiring an additional 64,154 shares during the period. Oppenheimer & Co. Inc. owned approximately 0.13% of Aspen Aerogels worth $2,839,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently made changes to their positions in ASPN. Peregrine Asset Advisers Inc. purchased a new position in Aspen Aerogels during the 3rd quarter valued at about $1,520,000. Sigma Planning Corp purchased a new position in Aspen Aerogels during the third quarter valued at $274,000. Mesirow Financial Investment Management Inc. bought a new stake in Aspen Aerogels in the 3rd quarter worth about $252,000. Bridgewater Advisors Inc. grew its stake in shares of Aspen Aerogels by 37.8% during the 3rd quarter. Bridgewater Advisors Inc. now owns 77,357 shares of the construction company's stock valued at $2,142,000 after purchasing an additional 21,218 shares during the period. Finally, Pursue Wealth Partners LLC purchased a new position in shares of Aspen Aerogels during the 3rd quarter valued at about $222,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. Barclays decreased their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Tuesday, November 12th. HC Wainwright reissued a "buy" rating and set a $30.00 price target on shares of Aspen Aerogels in a research report on Wednesday, October 16th. Benchmark reiterated a "buy" rating and set a $14.00 target price on shares of Aspen Aerogels in a research report on Thursday, August 8th. Piper Sandler cut their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating for the company in a report on Tuesday, October 22nd. Finally, StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a report on Wednesday. One analyst has rated the stock with a sell rating, nine have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $28.70.

Insider Buying and Selling at Aspen Aerogels

In related news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares of the company's stock, valued at $14,523,709.20. This trade represents a 11.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 60.96 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by corporate insiders.

Aspen Aerogels Trading Down 5.4 %

Aspen Aerogels stock traded down $0.82 during midday trading on Friday, reaching $14.28. 3,790,257 shares of the stock traded hands, compared to its average volume of 3,242,789. The company has a 50-day simple moving average of $22.04 and a two-hundred day simple moving average of $24.65. The company has a current ratio of 2.93, a quick ratio of 2.82 and a debt-to-equity ratio of 0.27. Aspen Aerogels, Inc. has a 12-month low of $9.89 and a 12-month high of $33.15. The firm has a market cap of $1.17 billion, a PE ratio of 1,428.00 and a beta of 2.21.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.